Sensitive ASX Announcement

Clinuvel, FDA agree in principle to Phase III study

Published: 15/03/12, 10:17am (AEST)2 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only